Molecular analysis of porin gene transcription in heterogenotypic multidrug-resistant Escherichia coli isolates from scouring calves

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 9, 2010, Pages 1926-1935

  Vinson, Heather M ^a   Gautam, Ablesh ^b   Olet, Susan ^a   Gibbs, Penelope S ^a   Barigye, Robert ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

QRT PCR; TolC; YiaT

Indexed keywords

MEMBRANE PROTEIN; PORIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; ESCHERICHIA COLI; GENETIC TRANSCRIPTION; GENOTYPE; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 77955608814     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq246     Document Type: Article

References (49)

1. Alcaide F, Santin M. Multidrug-resistant tuberculosis. Enferm Infec Microbiol Clin 2008; 26: 54-60.
2. Banerjee R, Schecter GF, Flood J et al. Extensively drug-resistant tuberculosis: new strains, new challenges. Expert Rev Anti Infect Ther 2008; 6: 713-24.
3. Bratu S, Brooks S, Burney S et al. Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemases KPC-2 in Brooklyn, New York. Clin Infect Dis 2007; 44: 972-5.
4. Brink A, Feldman C, Richards G et al. Emergence of extensive drug resistance (XDR) among Gram-negative bacilli in South Africa looms nearer. S Afr Med J 2008; 98: 586-92.
5. Elliott E, Brink A, Greune JV et al. In-vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with extended-spectrum β-lactamase. Clin Infect Dis 2006; 42: e95-8.
6. Jain A, Mondal R. Extensively drug-resistant tuberculosis: current challenges and threats. FEMS Immunol Med Microbiol 2008; 53: 145-50.
7. Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis 2006; 43: S49-56.
8. Vila J, Martí S, Sánchez-Céspedes J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 2007; 59: 1210-5.
9. McDermont PF, Walker RD, White DG. Antimicrobials: modes of action and mechanisms of resistance. Int J Toxicol 2003; 22: 135-43.
10. Tikhonova EB, Zgurskaya HI. AcrA, AcrB and TolC of Escherichia coli form a stable intermembrane multidrug efflux complex. J Biol Chem 2004; 279: 32116-24.
11. Chang G. Structure of MsbA from Vibrio cholerae: a multidrug resistance ABC transporter homolog in a closed conformation. J Mol Biol 2003; 330: 419-30.
12. Neyfakh AA, Bidnenko VE, Chen LB. Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system. Proc Natl Acad Sci USA 1991; 88: 4781-5.
13. Nikaido H, Vaara M. Molecular basis of bacterial outer membrane permeability. Microbiol Rev 1985; 49: 1-32.
14. Andersen C, Hughes C, Koronakis V. Chunnel vision. Export and efflux through bacterial channel-tunnels. EMBO Rep 2000; 1: 313-8.
15. Koronakis V, Sharff A, Koronakis E et al. Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 2000; 405: 914-9.
16. Nikaido H. Multidrug efflux pumps of Gram-negative bacteria. J Bacteriol 1996; 178: 5853-9.
17. Fralick A. Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli. J Bacteriol 1996; 178: 5803-5.
18. Nikaido H. Multidrug resistance in bacteria. Annu Rev Biochem 2009; 78: 119-46.
19. Chang CF, Mizushima S, Glaeser RM. Projected structure of the pore-forming OmpC protein from Escherichia coli outer membrane. Biophys J 1985; 47: 629-39.
20. Zakharov SD, Cramer WA. On the mechanism and pathway of colicin import across the E. coli outer membrane. Front Biosci 2004; 9: 1311-7.
21. Pagès JM, Chloë EJ, Winterhalter M. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nature Rev Microbiol 2008; 6: 893-903.
22. Pan YH, Liao CC, Kuo CC et al. The critical roles of polyamines in regulating ColE7 production and restricting ColE7 uptake of the colicin-producing Escherichia coli. J Biol Chem 2006; 281: 13083-91.
23. Cohen SP, McMurry LM, Levy SB. marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli. J Bacteriol 1988; 170: 5416-22.
24. Gambino L, Gracheck SJ, Miller PF. Overexpression of the MarA positive regulator is sufficient to confer multiple antibiotic resistance in Escherichia coli. J Bacteriol 1993; 175: 2888-94.
25. Li H, Wang BC, Xu WJ et al. Identification and network of outer membrane proteins regulating streptomycin resistance in Escherichia coli. J Proteome Res 2008; 7: 4040-9.
26. Mallea M, Chevalier J, Bornet C et al. Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology 1998; 144: 3003-9.
27. Lin M, Li H, Wan BC et al. Proteomic analysis of nalidixic acid resistance in Escherichia coli: identification and functional characterization of OM protein. J Proteome Res 2008; 7: 2399-405.
28. Benz B, Maier E, Gentsdiev I. TolC of Escherichia coli functions as an outer membrane channel. Zentralbl Bakteriol 1993; 278: 187-96.
29. Sulavik C, Houseweart C, Cramer C et al. Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob Agents Chemother 2001; 45: 1126-36.
30. Inokuchi K, Mutoh N, Matsuyama S et al. Primary structure of the ompF gene that codes for a major outer membrane protein of Escherichia coli K-12. Nucleic Acids Res 1982; 10: 6957-68.
31. Iyer R, Delcour AH. Complex inhibition of OmpF and OmpC bacterial porins by polyamines. J Biol Chem 1997; 272: 18595-601.
32. Aronoff SC. Outer membrane permeability in Pseudomonas cepacia: diminished porin content in a β-lactam-resistant mutant and in resistant cystic fibrosis isolates. Antimicrob Agents Chemother 1998; 32: 1636-9.
33. Toro CS, Lobos SR, Calderon I et al. Clinical isolate of a porin-less Salmonella typhi resistant to high levels of chloramphenicol. Antimicrob Agents Chemother 1990; 34: 1716-9.
34. Burns JL, Smith AL. A major outer-membrane protein functions as a porin in Haemophilus influenzae. J Gen Microbiol 1987; 133: 1273-8.
35. Fitzmaurice J, Glennon M, Duffy G et al. Application of real-time PCR and RT-PCR assays for the detection and quantification of VT1 and VT 2 toxin genes in E. coli O157:H7. Mol Cell Probes 2004; 18: 123-32.
36. Li H, Lin XM, Wang SY et al. Identification and antibody-therapeutic targeting of chloramphenicol-resistant outer membrane proteins in Escherichia coli. J Proteome Res 2007; 6: 3628-36.
37. Zhai Y, Saier MH Jr. The β-barrel finder (BBF) program, allowing identification of outer membrane β-barrel proteins encoded within prokaryotic genomes. Protein Sci 2002; 11: 2196-207.
38. Mizuno T, Wurtzel ET, Inouye M. Cloning of the regulatory genes (ompR and envZ) for the matrix proteins of the Escherichia coli outer membrane. J Bacteriol 1982; 150: 1462-6.
39. Black PN. The fadL gene product of Escherichia coli is an outer membrane protein required for uptake of long-chain fatty acids and involved in sensitivity to bacteriophage T2. J Bacteriol 1988; 170: 2850-4.
40. Cristalli G, DiRusso CC, Black PN. The amino-terminal region of the long-chain fatty acid transport protein FadL contains an externally exposed domain required for bacteriophage T2 binding. Arch Biochem Biophys 2000; 377: 324-33.
41. Macnab RM. Escherichia coli and Salmonella. In: Neidhardt FC, Curtiss R, Ingraham JL et al., eds. Cellular and Molecular Biology. 2nd Edn. Washington, DC: ASM Press, 1996; 123-45.
42. Paulsen IT, Park JH, Choi PS et al. A family of Gram-negative bacterial outer membrane factors that function in the export of proteins, carbohydrates, drugs and heavy metals. FEMS Microbiol Lett 1997; 156: 1-8.
43. Cowan SW, Garavito RM, Jansonius JN et al. The structure of OmpF porin in a tetragonal crystal form. Structure 1995; 3: 1041-50.
44. Sigumura K, Nishihara T. Purification, characterization, and primary structure of Escherichia coli protease VII with specificity for paired basic residues: identity of protease VII and OmpT. J Bacteriol 1988; 170: 5625-32.
45. Goldstein FW, Gutmann L, Williamson R et al. In vivo and in vitro emergence of simultaneous resistance to both β-lactam and aminoglycoside antibiotics in a strain of Serratia marcescens. Ann Microbiol 1983; 134A: 329-37.
46. Ranquin A, Van Gelder P. Maltoporin: sugar for physics and biology. Res Microbiol 2004; 155: 611-6.
47. Zhang DF, Jiang B, Xiang ZM et al. Functional characterization of altered outer membrane proteins for tetracycline resistance in Escherichia coli. Int J Antimicrob Agents 2008; 32: 315-9.
48. Stumpe S, Schmid R, Stephens DL et al. Identification of OmpT as the protease that hydrolyzes the antimicrobial peptide protamine before it enters growing cells of Escherichia coli. J Bacteriol 1998; 180: 4002-6.
49. Kanamaru S, Kurazono H, Ishitoya S et al. Distribution and genetic association of putative uropathogenic virulence factors iroN, iha, kpsMT, ompT and usp in Escherichia coli isolated from urinary tract infections in Japan. J Urol 2003; 170: 2490-3.